Eastgate Biotech Stock

Eastgate Biotech Equity

The The Equity of Eastgate Biotech (ETBI) as of Aug 14, 2026 is -4.62 M USD. In the previous year, The Equity was -2.48 M USD — a change of 86.13% (lower).

Equity

-4.62 MUSD

YoY

86.13%

Last updated:

In 2026, Eastgate Biotech's equity was -4.62 M USD, a 86.13% increase from the -2.48 M USD equity in the previous year.

Access this data via the Eulerpool API

Eastgate Biotech Stock analysis

What does Eastgate Biotech do? Eastgate Biotech Corp is a biotechnology company specialized in the development and marketing of natural nutritional products and medicines. The company was founded in Canada in 1999 and is headquartered in Toronto. Eastgate Biotech Corp is listed on the Canadian Securities Exchange and is one of the leading companies in the field of biological medicine. The company's business model is based on the research and development of natural supplements and medicines made from plant and animal ingredients. Eastgate Biotech Corp aims to develop products that improve the well-being of humans and animals and can be manufactured in a natural way. The company relies on the use of innovative technologies and advanced research methods. Eastgate Biotech Corp operates in various sectors including medicine, animal health, and agricultural production. In the field of medicine, the company specializes in the development of medicines for the treatment of various diseases. It uses plant and animal ingredients to create natural remedies. In the animal health sector, Eastgate Biotech Corp offers products specifically designed for the health and well-being of livestock. The company is also involved in agricultural production, offering products that contribute to increasing crop yields. The range of products offered by Eastgate Biotech Corp includes a wide variety of nutritional supplements and medicines. The company offers products that support a healthy diet and help meet the needs for vitamins and minerals. Additionally, Eastgate Biotech Corp offers products that help strengthen the immune system, lower cholesterol levels, or regulate blood pressure. Products for weight control and metabolism support are also available. Some of the most well-known products from Eastgate Biotech Corp include the nutritional supplements "Celergen" and "Deltaweight". "Celergen" is a highly effective preparation that can help increase physical performance, smooth the skin, and improve mental fitness. "Deltaweight" is a nutritional supplement specifically developed for those looking to lose weight or maintain their weight. The product contains a unique blend of natural ingredients that can stimulate metabolism and reduce appetite. Eastgate Biotech Corp has undergone impressive development in recent years and is now one of the leading companies in the field of biological medicine. The company has an experienced team of scientists and experts who support the development of new products. Eastgate Biotech Corp relies on the use of advanced research methods and innovative technologies to manufacture new preparations that can improve the well-being of humans and animals in a natural way. Eastgate Biotech is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Eastgate Biotech's Equity

Eastgate Biotech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Eastgate Biotech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Eastgate Biotech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Eastgate Biotech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Eastgate Biotech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Eastgate Biotech stock

The Equity of Eastgate Biotech is -4.62 M USD in 2026.

The Equity of Eastgate Biotech changed from -2.48 M USD to -4.62 M USD, representing a 86.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Eastgate Biotech since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Eastgate Biotech historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Eastgate Biotech

All Key Metrics — Eastgate Biotech